BE studies for cytotoxic drugs [Design Issues]

posted by kadarusuresh – 2010-02-26 08:21 (5967 d 22:16 ago) – Posting: # 4823
Views: 4,512

How to conduct the Bio-equivalence studies for the generic cytotoxic drugs (cancer drugs). The case if the BE is to be conducted for the cancer drugs the questions are,
1. Study to be conducted on healthy volunteers or patients.
2. What type of study to be conducted like fasting, fed or steady state.
3. what is the right approach for the BE study for EU and US markets.

Thanks in advance.


Edit: Category changed. [Helmut]

Complete thread:

UA Flag
Activity
 Admin contact
23,656 posts in 4,994 threads, 1,570 registered users;
275 visitors (0 registered, 275 guests [including 35 identified bots]).
Forum time: 07:38 CEST (Europe/Vienna)

It requires a very unusual mind
to undertake the analysis of the obvious.    Alfred North Whitehead

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5